Application | Comment | Organism |
---|---|---|
drug development | CDK2 is a target for development of small molecule inhibitors binding to the ATP binding pocket, determinations of binding structures and design of an inhibitor scaffold, overview | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-[[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene]-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one | - |
Homo sapiens | |
3-[[4-([[amino(imino)methyl]amino]sulfonyl)anilino]methylene]-2-oxo-2,3-dihydro-1H-indole | - |
Homo sapiens | |
4-(1,4-dioxo-1,4-dihydro-naphthalen-2-ylamino)-N-(2-hydroxy-ethyl)-benzenesulfonamide | - |
Homo sapiens | |
4-[2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazino]benzenesulfonamide | - |
Homo sapiens | |
4-[[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino]-N-(1,3-thiazol-2-yl)benzenesulfonamide | - |
Homo sapiens | |
4-[[(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)methyl]amino]-N-(2-pyridinyl)benzenesulfonamide | - |
Homo sapiens | |
6,7-dimethoxy-N-(3hydroxyphenyl)quinazolin-4-amine | - |
Homo sapiens | |
8-ethyl-2-[4-(4-methylpiperazin-1-yl)phenylamino]-8H-pyrido[2,3-d]pyrimidin-7-one | - |
Homo sapiens | |
flavopiridol | - |
Homo sapiens | |
H717 | - |
Homo sapiens | |
hymenialdisine | - |
Homo sapiens | |
indirubin-3'-monoxime | - |
Homo sapiens | |
indirubin-5-sulfonic acid | - |
Homo sapiens | |
isopentenyladenine | - |
Homo sapiens | |
additional information | analysis of interactions between small molecule inhibitors with the ATP binding pocket of CDK2, determinations of binding structures and design of an inhibitor scaffold, overview | Homo sapiens | |
N-(6-amino-pyrimidin-4-yl)-sulfanilic acid amide | - |
Homo sapiens | |
N-methyl-4-[[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino]benzenesulfonamide | - |
Homo sapiens | |
N-methyl-[4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl]methanesulfonamide | - |
Homo sapiens | |
N-[(9bR)-5-oxo-2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-alpha]isoindol-9-yl]-N'-pyridin-2-yl urea | - |
Homo sapiens | |
N-[(9bR)-5-oxo-2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-alpha]isoindol-9-yl]-N'-{5-[(2S)-pyrrolidin-2-yl]-1H-pyrazol-3-yl urea | - |
Homo sapiens | |
NU2058 | - |
Homo sapiens | |
NU6027 | - |
Homo sapiens | |
OL567 | - |
Homo sapiens | |
Olomoucine | - |
Homo sapiens | |
PKF049-365 | - |
Homo sapiens | |
purvalanol | - |
Homo sapiens | |
roscovitine | - |
Homo sapiens | |
staurosporine | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
CDK2 | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | ATP binding pocket structure, the pocket is a cleft located at the interface between two domains, involvd residues, overview | Homo sapiens |